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The relationship between virus and host cells is multifactorial and nonlinear. This indicates that the effect of an immune
response on infection can lead to several different outcomes. These include severe immunopathology. We seek to define
properties of CTL-induced pathology in viral infections and examine the implications for HIV disease progression. We find
that CTL-induced pathology is observed if the rate of viral replication is fast relative to the CTL responsiveness of the host.
Theoretical predictions are consistent with empirical data on LCMV infection. These conditions are also sufficient to induce
pathology in HIV infection. However, the absence of HIV-specific CTL can result in an equivalent depletion of the CD4 T cell
pool as a consequence of the short life span of activated T cells. A mathematical model describing the evolution of HIV
coreceptor usage in the context of lytic and nonlytic CD8 cell responses might account for the relatively long time span
required to result in disease. Viral evolution toward parameter ranges allowing CTL-induced pathology is difficult to achieve.
It requires the emergence of fast viral replication together with escape from nonlytic CTL responses. However, according to
the model, fast viral replication can result in the evolution of virus strains that are susceptible to chemokine-mediated
inhibition of viral replication. © 2000 Academic Press
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In many virus infections, especially with noncytopathic
viruses, the lytic CTL response has been shown to be
necessary to eliminate or control the disease (Jeffery et
al., 1999; Kagi and Hengartner, 1996; Kagi et al., 1995;
Saah et al., 1998; Schmitz et al., 1999). However, at the
ame time, the lytic CTL response can be detrimental to
he host, causing severe immunopathology following the
estruction of host cells. The classic case study for such
mmunopathology is murine LCMV infection (Lehmann-
rube, 1971; Moskophidis et al., 1993; Zinkernagel et al.,
996). In the absence of a CTL response, for example,
uring neonatal infection (Moskophidis et al., 1993) or
TL exhaustion (Bocharov, 1998; Moskophidis et al.,
993; Wodarz et al., 1998), the mouse remains healthy
ecause of the noncytopathic nature of the virus. The
resence of an efficient CTL response can successfully
ontrol the infection, while less efficient LCMV-specific
TL can lead to severe immunopathological effects,
haracterized by wasting of the mice (Clark et al., 1995;
atloubian et al., 1999; Moskophidis et al., 1993, 1995;
inkernagel et al., 1996, 1999). This is promoted by faster
eplicating virus strains as well as relatively high inocu-
um doses (Moskophidis et al., 1995). These findings are
n agreement with a theoretical study showing that tissue
amage due to immunopathology is likely to be most
evere in hosts characterized by a CTL response of
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94elatively low or intermediate efficacy (Krakauer and
owak, 1999).
CTL-mediated immunopathology has also been sug-
ested as a possible reason for the eventual develop-
ent of AIDS (Zinkernagel, 1994, 1995; Zinkernagel and
engartner, 1994; Zinkernagel et al., 1999). However, the
fficacy and role of CTL in HIV infection, as well as the
ytotoxicity of the virus, are still highly controversial (Kle-
erman et al., 1996). In addition, it is unclear how CTL-
mediated pathology could account for the depletion of
the CD41 T cell pool, given that during the asymptomatic
period of the infection only a small proportion of the
overall T cell population is infected and that the replica-
tion cycle of the virus cannot be completed in resting T
cells (Heinzinger et al., 1994; Stevenson, 1994, 1996;
Stevenson et al., 1995). Thus, virus-induced bystander
killing of uninfected T cells has been proposed to ac-
count for the eventual loss of CD4 cells (Banda et al.,
1992; Finkel and Banda, 1994; Gougeon et al., 1993a,b;
Kameoka et al., 1997), although theory suggests that this
will not be of sufficient magnitude (Krakauer and Nowak,
1999). Moreover, it is not clear how CTL-mediated pa-
thology as a cause of AIDS can be reconciled with the
long time period required to reach the end-stage of the
disease.
Here we use mathematical models to further examine
the properties of CTL-induced pathology as well as the
implications for HIV infection. The interactions between
virus, target cells, and the immune system are highly
nonlinear. Thus, the equilibrium outcomes of an infection
are frequently counterintuitive. Mathematical models
95CTL-INDUCED PATHOLOGY AND IMPLICATIONS FOR HIVtake us beyond verbal or graphical reasoning and pro-
vide a solid framework upon which to build experiments
and generate hypotheses. Based on the models we offer
an exact definition of CTL-mediated pathology. We inves-
tigate how it might account for T cell depletion in HIV-
infected patients and suggest a mechanism for the rel-
atively long phase of disease progression.
RESULTS AND DISCUSSION
What is CTL-induced pathology?
We consider a basic model describing the interaction
between the virus, its host cells, and a lytic CTL re-
sponse. We use this model in order to examine the
properties of CTL-induced pathology brought about by
direct lysis of target cells by specific CTL. Immunopa-
thology brought about by cytokine production or by-
stander activation is not analyzed and requires different
treatment. The model contains three variables: unin-
fected cells, x, infected cells, y, and CTL, z. It is de-
scribed mathematically under Materials and Methods
and schematically in Fig. 1. Since the CTL response is
likely to be detrimental to the host if the virus is noncy-
totoxic (Krakauer and Nowak, 1999), we examine this
scenario assuming that the life span of uninfected cells
equals that of infected cells in the absence of immunity
(a 5 d). The degree of CTL-mediated pathology is de-
scribed in the model by the total number of target cells
found in the presence of the virus and the CTL response,
i.e., by x (1) 1 y (1) (see Materials and Methods). Figure 2
displays the properties of CTL-induced pathology. Pa-
thology is determined mainly by the rate of viral replica-
tion relative to the strength of the CTL response. If the
CTL responsiveness is low relative to the replication rate
of the virus, then the CTL can induce a significant reduc-
tion of the total number of target cells. If the CTL respon-
siveness is high relative to the rate of viral replication,
then the CTL do not induce tissue pathology, but contrib-
ute to the resolution of the infection. Therefore, the faster
the replication rate of the virus, the stronger the CTL
response must be in order to have a beneficial effect on
the host and to avoid CTL-induced pathology. Thus, with
slowly replicating viruses, the lytic CTL response is un-
likely to result in high degrees of tissue damage. On the
other hand, with fast replicating virus strains, the lytic
CTL response is likely to be detrimental. The reason for
these patterns is shown in Fig. 3. If the virus replicates at
a fast rate, the CTL suppress the number of infected
cells, while the replicating pathogen depletes the num-
ber of uninfected cells. On the other hand, for slow viral
replication, the number of infected cells is kept at low
levels while virus replication fails to deplete the popula-
tion of uninfected cells.
Although we have explored the properties of CTL-
induced pathology assuming a noncytotoxic virus, our
results do not strictly depend on this assumption. Ingeneral, the presence of a CTL response can lead to a
reduction in the total number of target cells if the cyto-
pathicity of the virus is low relative to the rate of viral
replication. In terms of the model, CTL can result in
tissue damage if a , (lb) 1/ 2, where a denotes viral
cytopathicity and lb correlates with the replication kinet-
ics of the virus (Krakauer and Nowak, 1999). Therefore, if
the virus replicates at a fast rate, CTL can induce pathol-
ogy even if the virus is relatively cytotoxic.
Based on these findings we can give a definition of
CTL-induced pathology. CTL-mediated pathology occurs
if the sum of uninfected and infected target cells at
equilibrium is smaller in the presence of a CTL response
than in the absence of CTL. CTL-induced pathology is
not a property of the host alone. It is likely to be observed
with viruses that are characterized by a fast rate of
replication relative to the rate of virus-induced cytotoxic-
ity. The degree of CTL-induced pathology is promoted by
a fast rate of viral replication relative to the CTL respon-
siveness of the host. In this case, the immune system
keeps the number of infected cells at low levels, while
the virus reduces the number of uninfected cells.
CTL-induced pathology in LCMV infection
LCMV infection in mice is a major experimental model
used to study the properties of CTL-induced pathology.
The outcome of LCMV infection depends on a complex
balance between host and viral parameters as well as
initial conditions. The outcomes of infection include CTL-
mediated resolution of disease (Zinkernagel, 1993), CTL
exhaustion (Moskophidis et al., 1993; Wodarz et al.,
1998), CTL-induced pathology (Zinkernagel, 1993, 1996),
and stable coexistence between persistent virus replica-
tion and a CTL response (C. Bartholdy, J. P. Christensen,
D. Wodarz, and A. R. Thomsen, submitted for publication).
CTL-induced pathology has been shown to be depen-
dent on lysis of infected cells and consequent tissue
damage (Thomsen et al., in press). In agreement with our
model, experimental data indicate that the occurrence of
CTL-induced pathology depends on the rate of viral rep-
lication and the strength of the host response (Matlou-
bian et al., 1999; Thomsen et al., in press; Zinkernagel,
1993). A sufficiently strong CTL response results in res-
olution of the infection. On the other hand, CTL exhaus-
tion results in persistent viral replication at high loads.
Because of the noncytopathic nature of the virus, no
tissue damage is observed and the host does not de-
velop any symptoms. On the other hand, a CTL response
of intermediate strength can result in severe CTL-in-
duced tissue damage and wasting of the mouse. CTL-
induced pathology is most likely to occur with virus
strains characterized by fast replication kinetics. In ad-
dition, the presence of soluble factors such as IFN-g,
reducing the overall replication rate of the virus, reduces
the amount of tissue damage and promotes a beneficial
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96 WODARZ AND KRAKAUERFIG. 1. Schematic representation of the mathematical models. Rate constants are given for the basic infection models. For details, see Materials
and Methods. (a) The basic virus infection model. Susceptible host cells are produced and react with free virus to give rise to infected cells. Infected
cells produce new virus particles and become lysed by the CTL response that has expanded specifically in response to viral antigen. (b) A model
for T cell infection by HIV. It is an extension of the basic virus infection model to account for the experimental observation that HIV can complete its
replication cycle only in activated T cells. We assume that resting T cells are produced at a constant rate and that responsive T cells become activated
and thus susceptible to HIV by exposure to viral antigen. We include the possibility of feedback in the activation term. That is, if the value of e is low,
he rate of T cell activation increases if the number of activated T cells falls to low levels. (c) Principles underlying the evolutionary model of HIV
oreceptor usage. We assume that HIV can infect mainly two cell types: T cells and macrophages. While T cells can be infected by using either the
CR5 or the CXCR4 coreceptors, macrophages can be infected only by using CCR5. HIV infects CCR5-bearing cells with a probability q and
XCR4-bearing cells with a probability 1 2 q. Hence a value of q 5 1 represents complete viral specialization on CCR5, while a value of q 5 0
epresents complete viral specialization on CXCR4. The CD8 cell response has two modes of antiviral activity. It can lyse infected cells, and in accord
ith sequence data, we assume that CTL-mediated lysis is directed mainly at T cells. On the other hand, CD8 cells secrete b-chemokines that inhibit
iral entry into CCR5-bearing cells. The b-chemokines do not inhibit infection of virus strains using the CXCR4 coreceptor.
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97CTL-INDUCED PATHOLOGY AND IMPLICATIONS FOR HIVeffect of the CTL (Thomsen et al., in press). With the
lowly replicating Armstrong strain, the absence of IFN-g
does not significantly compromise virus control. Al-
though the virus can replicate persistently in the pres-
ence of CTL, significant amounts of CTL-induced pathol-
ogy are not observed (Thomsen et al., in press). On the
ther hand, with the faster replicating Traub strain, the
bsence of IFN-g results in severe tissue damage and
asting of the host (Thomsen et al., in press). This is
ecause the replication rate of this strain is fast, result-
ng in CTL-induced pathology unless the replication ki-
etics are reduced by soluble immune mediators.
TL-induced pathology and CD4 cell depletion in HIV
nfection
In the above sections we determined that occurrence
f CTL-induced pathology does not require the virus to
e noncytotoxic, but is likely to be observed if viral
ytotoxicity is low relative to the rate of viral replication.
hus, if HIV replicates at a fast rate, then CTL might
ontribute to pathology even if HIV also directly kills the
ell. If CTL-induced pathology is a determinant of HIV
isease progression, we must explain how this is pos-
ible provided that HIV completes its replication cycle
nly in activated T cells, a restricted subset of the overall
D4 T cell population (Heinzinger et al., 1994; Stevenson,
994, 1996; Stevenson et al., 1995). In order to examine
FIG. 2. Basic properties of CTL-induced pathology, defined by a
reduction of the total number of target cells in the presence of CTL,
compared to the absence of CTL. We assume that the virus is noncy-
topathic. CTL-induced pathology is most likely to occur at a low or
intermediate efficacy of the CTL response (c 3 p). In addition, the
replication rate of the virus plays an important role. The faster the
replication kinetics of the virus, the more severe the degree of pathol-
ogy observed. If the virus replicates at a fast rate, a significant reduc-
tion in the total number of target cells will be observed even in the
presence of a relatively strong CTL response. If the virus replicates
slowly, any degree of immunopathology is observed only in the pres-
ence of inefficient CTL. Thus, for slowly replicating viruses, an increase
in the CTL responsiveness is likely to benefit the host, while for faster
replicating strains, the opposite applies (see vertical dashed line and
arrows). Parameters were chosen as follows: l 5 10; d 5 0.1; a 5
.1; k 5 1; u 5 1; b 5 0.1.his paradox, we extend the above model to account for
he interactions among HIV, CD4 T cells, and the CTL
Cesponse. The model consists of five variables: resting
ninfected CD4 T cells, s, activated uninfected T cells, x,
nfected T cells, y, free virus, v, and CTL, z. In contrast to
he basic virus infection model we assume that HIV
ompletes it replication cycle only in activated CD4 T
ells and that T cell activation occurs in response to viral
ntigen. This can include bystander activation resulting
rom the high viral load observed in primary infection.
he model is explained graphically in Fig. 1.
The exact mathematical consequences of assuming
hat only activated T cells become infected are set out in
etail in Wodarz et al. (1999a). Here we are interested in
hether CTL-mediated pathology can lead to a depletion
f the overall CD4 T cell count at equilibrium. In the
revious section we found that CTL-induced pathology is
he consequence of fast viral replication relative to the
TL responsiveness of the host. In the current model we
ust break down the overall replication rate of the virus
nto the rate of virus production and the rate of entry into
usceptible target cells. If the rate of virus production is
ast relative to the CTL responsiveness of the host, the
umber of uninfected activated and resting CD4 T cells
s reduced to very low numbers, and the CTL response
FIG. 3. Dependence of CTL-induced pathology on the replication rate
of the virus in the basic model of virus dynamics. The effects of viral
infectivity, b, and the rate of virus production, k, are identical. (a) The
aster the rate of viral replication, the stronger the degree of pathology.
b) This is because an increase in the rate of viral replication depletes
he number of uninfected cells, while driving the number of infected
ells toward an asymptotic level that is kept low due to the activity of
TL. Parameters were chosen as follows: l 5 10; d 5 0.1; a 5 0.1;
k 5 1; u 5 1; c 5 0.2; b 5 0.1; p 5 1.
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98 WODARZ AND KRAKAUERsuppresses the number of infected cells (see Materials
and Methods). This immunopathology can lead to the
depletion of the T helper cell pool. The reason is that a
fast rate of virus production results in higher levels of
free virions exposed to the immune system. This in turn
results in a higher degree of T cell activation that en-
ables the virus to infect cells. Continuous activation of
the resting CD4 T cell pool, in combination with infection
and CTL-mediated killing, can lead to depletion of the
overall T helper cell population.
On the other hand, if the rate of virus entry into sus-
ceptible cells is large relative to the CTL responsiveness
of the host, the situation is more complicated (see Ma-
terials and Methods). The CTL response suppresses the
number of infected T helper cells, and the high rate of
virus entry results in low numbers of activated uninfected
CD4 T cells. Whether the number of resting CD4 T cells
is also depleted depends on the exact assumptions
underlying the term describing T cell activation. The
resting T cell pool is depleted only if the rate of T cell
activation significantly increases when the number of
activated T cells falls to low levels, i.e., for low e. This
assumes the presence of a feedback mechanism acting
on the level of activated CD4 T cells. While this is a
mathematical possibility, the biological interpretation of
this mechanism remains uncertain and should therefore
be treated with some skepticism.
To summarize, a fast rate of viral replication (espe-
cially virion production) relative to the CTL responsive-
ness of the host results in immunopathological depletion
of the CD4 T cell pool even when the virus infects only
activated T cells and if the virus is cytotoxic to a certain
degree. A fast rate of virion production relative to the CTL
responsiveness results in CTL-induced pathology, while
the effect of a fast rate of viral entry on the degree of
immunopathology depends on the exact assumptions
underlying the T cell activation term.
HIV dynamics in the absence of CTL
It has been suggested that therapeutic reduction of
the number of HIV-specific CTL could be beneficial for
the patient, especially if the virus is noncytopathic (Zink-
ernagel, 1994, 1995; Zinkernagel and Hengartner, 1994).
Here we examine whether or not the absence of a CTL
response would be advantageous for the host assuming
for now that the virus is noncytopathic. The answer
depends on the life span of activated T cells relative to
resting CD4 T cells. For fast viral replication kinetics, the
model predicts that the sum of infected and uninfected T
cells in the absence of a lytic CTL response is approxi-
mately j/d, that is, the production rate of resting cells
divided by the death rate of activated T cells. In the
absence of the infection, the total number of CD4 T cells
is given by j/f, where f is the death rate of resting CD4
cells. Thus, if the death rate of activated T cells is
C
mignificantly higher than that of resting T cells (d @ f ), a
ast rate of viral replication in the absence of a CTL
esponse can still produce a reduction of the CD4 T cell
ount. For example, the CD4 T cell count can be reduced
rom 1000 to 200 if the death rate of activated cells is five
imes higher than that of resting T cells. This is true if the
ate of virion production is fast and might also hold for
ast rates of viral entry into host cells given the restric-
ions discussed in the previous section.
Note that this result has important implications for the
esign of experiments to test possible mechanisms re-
ponsible for T cell depletion in HIV infection. One way to
est whether viral cytopathicity contributes to a reduction
f the CD4 cell population is to deplete macaques of CD8
cells (Schmitz et al., 1999) and to follow CD4 T cell
ounts during primary infection. Our model predicts that
ven if HIV were noncytopathic and the host depleted of
D8 T cells, depletion of the T helper cell pool can still
e observed. This is because viral replication can acti-
ate a large number of T cells, and activated T cells have
short life span.
IV disease progression and virus evolution
Experimental data indicate that disease status and
isease progression in HIV-infected patients correlate
ith the rate of viral replication. It has been found that
low disease progression is associated with the pres-
nce of slowly replicating virus strains, e.g., due to a
eletion in nef (Deacon et al., 1995; Miller and Greene,
996). Moreover, at the beginning of the asymptomatic
eriod, slowly replicating strains dominate the virus pop-
lation while the replication kinetics of the virus increase
uring disease progression until the development of
IDS (Asjo et al., 1986; Connor and Ho, 1994; Fenyo et al.,
988; Ferbas et al., 1996; Gruters et al., 1991; Tersmette et
l., 1989).
Recent empirical (Kalams et al., 1999a; Kalams and
alker, 1998; Lifson et al., 2000; Rosenberg et al., 1997,
999; Rosenberg and Walker, 1998) and theoretical stud-
es (Wodarz et al., 1999b,c; Wodarz and Nowak, 1999)
ave revealed the importance of the dynamical interac-
ions occurring during primary infection for the immune
ystem to control viral replication in the long term. The
igh virus load typically observed during the primary
hase is thought to induce impairment of T helper cells,
hich in turn results in the failure to establish an efficient
TL memory response (Borrow et al., 1996, 1998; Kalams
t al., 1999b; Kalams and Walker, 1998; Thomsen et al.,
996, 1998).
Hence, infected patients could be faced by fast-repli-
ating virus strains and a relatively weak CTL response.
his is the parameter region in which T cell depletion
nduced by CTL-mediated lysis is likely to occur. Thus,
TL-induced pathology could contribute to the develop-
ent of AIDS. Note that this does not require the as-
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99CTL-INDUCED PATHOLOGY AND IMPLICATIONS FOR HIVsumption that HIV is noncytopathic. These dynamics are
compatible with the assumption that HIV can be cyto-
pathic in T cells, given that the rate of viral replication is
sufficiently fast.
According to this argument, evolution toward faster
replicating HIV strains could be a major driving force
underlying progression to AIDS. However, given the high
mutation rate of HIV (Bebenek et al., 1989; Nowak, 1990;
Roberts et al., 1988), it is hard to explain why it takes
such a long time to develop AIDS. The virus population
would be expected to evolve to sufficiently fast replica-
tion kinetics in a shorter period of time, and pathology
should set in earlier. In order to account for the delay in
disease progression we must expand the model by in-
troducing further details regarding the replication cycle
of HIV. We address this problem in the next section.
An evolutionary model of HIV coreceptor usage
Here we introduce a model taking into account the
tropism of HIV for the CCR5 and CXCR4 coreceptors, as
well as the susceptibility of virus strains with different
tropisms to lytic and nonlytic CTL responses. CCR5
tropic HIV strains can infect both macrophages and pri-
mary CD4 T cells. CXCR4 tropic HIV can infect CD4 T
cells only. Sequence analysis of synonymous and non-
synonymous mutations suggests that the lytic CTL re-
sponse is less efficient against infected macrophages
compared to T cells (Bonhoeffer et al., 1995). On the
ther hand, in contrast to CXCR4-tropic HIV, CCR5-tropic
trains are inhibited by CD8 T-cell-secreted b-chemo-
kines. Thus, a switch to CXCR4 tropism is equivalent to
an increase in the death rate of infected cells, as well as
to escape from nonlytic CD8 responses. We capture
these assumptions in our model. It is described sche-
matically in Fig. 1, and mathematical details are found
under Materials and Methods.
Model predictions
In this model, significant levels of CD4 T cell depletion
due to CTL-induced pathology are likely only if HIV has
largely escaped nonlytic CD8 cell-mediated activity, for
example, by switching to CXCR4 tropism. This is be-
cause chemokines strongly reduce the replication kinet-
ics of the virus and therefore counter immunopathologi-
cal effects. In the following we examine how the evolu-
tion of coreceptor usage depends on viral and host
parameters. In contrast to the previous sections, here we
allow the virus population to evolve new cell tropisms
under immune selection pressures. Preference for the
CXCR4 and CCR5 coreceptors is captured in the param-
eter q and is treated as a continuous trait varying be-
tween 0 and 1. The higher the value of q, the higher the
tropism for CCR5 and the lower the tropism for CXCR4. A
value of q 5 0 corresponds to specialization on CXCR4,
while q 5 1 corresponds to specialization on CCR5. We
t
ianalyze how changes in the rate of viral replication
influence the evolutionary dynamics of coreceptor us-
age. We call the level of coreceptor usage (q) to which
the virus population evolves the evolutionarily stable
state.
Figure 4 shows the evolutionarily stable state of core-
ceptor usage depending on the viral replication rate. We
consider the rate of target cell entry (b), although chang-
ing the rate of virion production by infected cells (k) has
an identical effect. Assuming that the rate of viral repli-
cation is fast enough to allow T cell infection (Wodarz et
al., 1999a), increasing the replication rate of HIV results
in evolution toward higher degrees of CCR5 tropism.
Above we established that CTL-induced pathology re-
quires relatively fast replication kinetics of HIV in com-
bination with CXCR4 tropism. Since fast replication fa-
vors the evolution toward CCR5 tropism, infection is
inhibited by nonlytic CD8 cell responses and pathology
can be prevented. In the context of these results, how
can fast-replicating virus strains evolve toward CXCR4
tropism? This is facilitated by a high rate of T cell acti-
vation in response to antigen, l1 (Fig. 4). In biological
erms, this can be achieved through an accumulation of
pportunistic infections in the face of HIV-induced im-
une subversion (Phair, 1999).
To summarize, the model predicts a long time span
ntil AIDS develops as a result of CTL-induced pathol-
gy. Pathology requires a fast rate of viral replication
ombined with the evolution of CXCR4 tropic strains.
owever, a fast rate of viral replication tends to lead to
FIG. 4. The degree of coreceptor usage of HIV evolves depending on
the rate of viral infectivity, b, and the rate of CD4 T cell activation, l1.
he result is the same when changing the rate of virion production, k.
he faster the rate of viral replication, the higher the degree of CCR5
ropism seen in the HIV population. Evolution of HIV strains that are
ore CXCR4 tropic and replicate at a fast rate is observed if the rate of
D4 T cell activation (l1) is high. This can be caused by an accumu-
ation of persistent pathogens during the asymptomatic phase of the
nfection. Parameters were chosen as follows: l 2 5 10; d 1 5 0.1; d 2 5
.1; a 1 5 0.1; a 2 5 0.1; k 5 1; u 5 1; c 5 0.2; b 5 0.1; p 1 5 10;
p 2 5 1.he evolution of CCR5 tropic strains that are efficiently
nhibited by CTL-secreted b-chemokines.
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100 WODARZ AND KRAKAUERConclusion
We used mathematical models to study properties of
CTL-induced pathology in viral infections. The models
allow us to precisely define pathology and to explore the
dynamical interactions that could eventually result in
disease. The basic results are summarized in Table 1.
CTL-induced pathology not only occurs with noncyto-
pathic viruses, but is likely to be observed if viral cyto-
pathicity is low relative to the replication kinetics of the
virus. CTL-induced pathology is promoted by a fast rate
of viral replication relative to the CTL responsiveness of
the host. While the CTL suppress the number of infected
cells, viral replication reduces the number of uninfected
cells to low levels. If the CTL response is sufficiently
strong to overcome the rate of viral replication, then the
CTL are beneficial to the host and resolve the infection
without the occurrence of significant tissue damage.
These results are in good agreement with experimental
studies on CTL-induced pathology in LCMV infection.
The finding that a fast rate of viral replication relative to
the CTL responsiveness of the host promotes CTL-in-
duced pathology also holds true for HIV infection. We
have explored specific mathematical models to investi-
gate the role of CTL-induced pathology in the context of
HIV infection. The role of virus-induced cell killing versus
host-induced cell killing is still a controversial area of
research (Krakauer and Payne, 1997). Our models sug-
gest that in a setting of relatively weak CTL-mediated
immunity and fast viral replication, CTL-induced pathol-
ogy is likely to contribute to CD4 T cell depletion, even if
HIV is to a certain degree cytotoxic. Experimental data on
the rate of viral replication and the efficacy of the immune
response in HIV infection are consistent with the theo-
retical results presented here. Note, however, that our
models do not suggest that CTL-induced pathology is the
T
Summary of
Model
Basic properties of CTL-induced
pathology (e.g., in LCMV infection)
• CTL-mediated pa
presence of a CT
observed if the r
D4 cell infection and CTL-induced
pathology (HIV)
• Fast viral replica
• The absence of a
noncytopathic, be
• CTL-induced pat
sufficiently to ove
volution of HIV coreceptor usage and
disease progression
• In vivo evolution
such strains are
• This can accoun
CTL-induced pat
e.g., by the accuoverriding factor responsible for disease progression.
Indeed, in the setting of fast viral replication, direct viralcytotoxicity can also contribute to depletion of the T cell
pool. However, our models do suggest that a combination
of both mechanisms contributes to disease progression.
If CTL-induced pathology does contribute to disease
progression, it has been suggested that elimination of
HIV-specific CTL might be beneficial for the host (Zink-
ernagel, 1994, 1995; Zinkernagel and Hengartner, 1994).
However, our mathematical models caution against this
strategy. They suggest that the safest way in which to
prevent progression to AIDS is to induce a CTL response
of sufficient strength to overcome the replication rate of
the virus. Fast viral replication in the absence of a CTL
response is likely to result in CD4 T cell depletion
through natural attrition of activated T cells.
Finally, the more detailed model describing the inter-
action between HIV coreceptor usage and lytic and non-
lytic CTL responses provides some insight into the rela-
tively long time span required for the development of
AIDS. While a fast rate of viral replication is required for
CTL-induced pathology, fast replication kinetics favor
evolution of CCR5 tropism and therefore successful che-
mokine-mediated prevention of disease. We suggest that
a high rate of CD4 T cell activation in response to the
accumulation of persistent opportunistic pathogens over
time is required to result in the evolution of fast-replicat-
ing and CXCR4 tropic variants and hence in the devel-
opment of disease. This is consistent with the empirical
finding that in advanced HIV disease, shorter survival is
associated with increased levels of T lymphocyte activa-
tion (Giorgi et al., 1999).
Again, it is important to note that these evolutionary
dynamics hold true even if viral cytotoxicity contributes to
disease development. These dynamics must be consid-
ered in a more general framework where viral evolution
is a driving force in HIV disease progression. Mathemat-
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101CTL-INDUCED PATHOLOGY AND IMPLICATIONS FOR HIVsity can result in a gradual deterioration of antiviral
immunity, which eventually culminates in the collapse of
the CD4 T cell population and the development of AIDS
(de Boer and Boerlijst, 1994; Nowak et al., 1991, 1995;
Regoes et al., 1998; Wodarz et al. (1998). These models
xplicitly take into account the ability of the virus to
mpair immune responses, for example, by killing CD4 T
ells. However, as discussed in the present paper, sim-
lar conclusions can be attained if the CTL are respon-
ible for T cell depletion, even when HIV is cytotoxic to a
egree. Hence, further experimental work is required to
recisely define the role of virus-induced versus host-
nduced T cell killing for HIV disease progression.
MATERIALS AND METHODS
asic dynamics between virus and CTL
The basic model describing the interactions between
replicating virus population and a specific antiviral CTL
esponse takes into account four variables: uninfected
ells, x, infected cells, y, virus, v, and CTL, z. It is given
y the following set of differential equations:
x˙ 5 l 2 dx 2 bxy
y˙ 5 bxy 2 ay 2 pyz
v˙ 5 ky 2 uv
z˙ 5 cy 2 bz. (1)
Uninfected cells are produced at a rate l, die at a rate
x, and become infected at a rate bxv. Infected cells die
at a rate ay, produce virions at a rate ky, and are lysed
by CTL at a rate pyz. Free virus particles decay at a rate
uv. The CTL population expands at a rate cy and decays
at a rate bz.
When modeling CTL dynamics, the exact functional
response used to study CTL expansion is an important
issue. Various models have been used in the theoretical
literature. Thus, Nowak and Bangham (1996) used a
response where CTL expansion was proportional to the
number of CTL. While this more accurately describes the
process of CTL proliferation, it lacks a saturation term.
As a consequence, equilibrium virus load is determined
only by a restricted set of immunological parameters,
and the CTL population grows to ever-increasing values
if the rate of CTL-mediated killing, p, is low. The func-
tional response used in the present paper is an alterna-
tive, simply describing CTL expansion in response to the
presence of antigen. In this case, equilibrium virus load
is determined by a combination of host and viral param-
eters. The consequence of different functional responses
to describe CTL dynamics has been analyzed and com-
pared in detail by de Boer and Perelson (1998) and
Wodarz et al. (2000).If the basic reproductive ratio of the virus (R 0 5 bl/
da) is greater than unity, the system converges to an
equilibrium describing persistent virus replication in the
presence of a CTL response. It is given by E1.
y ~1! 5
b~b9x ~1! 2 a!
pc
, v ~1! 5 ky ~1!/u, z ~1! 5
b9x ~1! 2 a
p
,
where x ~1! is given by
x ~1! 5
b9ab 2 dpc 1 ˛~b9ab 2 dpc! 2 1 4bb9 2lpc
2bb9 2
We define b9 5 bk/u.
HIV dynamics and T cell activation
The model describing the interactions between CD4 T
cells, HIV, and the CTL response takes into account five
variables: resting uninfected CD4 T cells, s, activated
uninfected T cells, x, infected T cells, y, free virus, v, and
CTL, z. It is given by the following set of differential
equations:
s˙ 5 j 2 fs 2
rsv
x 1 e
x˙ 5
rsv
x 1 e
2 dx 2 bxv
y˙ 5 bxv 2 ay 2 pyz
v˙ 5 ky 2 uv
z˙ 5 cy 2 bz. (2)
We assume that HIV infects only activated T cells and
that the virus induces CD4 cell activation. Resting CD4 T
cells are produced at a rate j, die at a rate fs, and
ecome activated by virus at a rate rsv/( x 1 e). This
assumes that the rate of T cell activation is a function of
the number of T cells that are already activated. If e is
mall, the rate of T cell activation significantly increases
f the number of activated T cells is low. Activated T cells
ie at a rate dx and become infected at a rate bxv.
Infected cells produce free virus at a rate ky, die at a rate
ay, and are killed by CTL at a rate pyz. Free virus decays
at a rate uv. The CTL population expands in response to
antigen at a rate cy and decays at a rate bz. Persistent
virus replication in the presence of a CTL response is
described by an equilibrium given by a third-degree
polynomial expression, which we omit to include for
aesthetic reasons. In this model, a fast rate of viral
replication relative to the efficacy of the CTL response
results in depletion of uninfected activated T helper cells
at equilibrium, while the CTL suppress the number of
infected cells. The number of resting cells at equilibrium
is given by s* 5 j/[ f 1 rv*/( x* 1 e)], where x* and v*
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102 WODARZ AND KRAKAUERdenote the equilibrium number of uninfected activated T
cells and the equilibrium level of free virus, respectively.
An increase in the rate of virion production, k, results in
an increase in v* and a decrease in x*. This can lead to
depletion of the number of resting T cells. An increase in
the rate of target cell entry, b, results only in a decrease
in x*. Hence, whether the resting T cell pool can be
depleted by a high value of b depends on the value of e.
n biological terms, a low value of e indicates increased
rates of T cell activation if the number of activated T cells
is low. If such a feedback mechanism is involved in
regulating T cell activation, an increase in the rate of
target cell entry, b, can lead to a depletion of the resting
T helper cell pool. However, in biological terms it is not
possible to tell whether such a feedback mechanism
exists and we include it for completeness, as it remains
a possibility.
Modeling viral evolution
The model describing the evolutionary dynamics of
coreceptor usage in HIV infection includes six variables:
uninfected T cells, x 1, uninfected macrophages, x 2, in-
ected T cells, y 1, infected macrophages, y 2, free virus, v,
and CTL, z. It is given by the following set of differential
equations:
x˙1 5
l1v
ev 1 1
2 d1x1 2
qbx1v
p1z 1 1
2 ~1 2 q!bx1v
x˙2 5 l2 2 d2x2 2
qbx2v
p1z 1 1
y˙1 5
qbx1v
p1z 1 1
1 ~1 2 q!bx1v 2 a1y1 2 p2y1z
y˙2 5
qbx2v
p1z 1 1
2 a2y2
v˙ 5 k~y1 1 y2! 2 uv
z˙ 5 c~y1 1 y2! 2 bz. (3)
The parameter qb denotes the rate of entry into cells
earing the CCR5 coreceptor. We assume that increased
ropism for one coreceptor is associated with decreased
ropism for the other (Scarlatti et al., 1997). Thus, the rate
f infection of cells bearing the CXCR4 coreceptor is
iven by (1 2 q)b.
Uninfected susceptible (i.e., activated) T cells are gen-
erated in response to antigen at a rate l 1v/(ev 1 1) and
die at a rate d 1x 1. They may be infected by virus using
either the CCR5 coreceptor at a rate qbx 1v or the CXCR4
eceptor at a rate (1 2 q)bx1v. Uninfected macrophages
are produced at a rate l2, die at a rate d 2x 2, and become
infected by CCR5 tropic virus only at a rate qbx 2v. In-
ected T cells and macrophages die at a rate a 1y 1 and
2y 2, respectively. Free virus is produced by the infectedells at a rate k( y 1 1 y 2) and decays at a rate uv. The
CD8 T cell population expands in response to infected
cells at a rate c( y 1 1 y 2) and decays at a rate bz. The
CD8 T cells have both lytic and nonlytic activities. The
model assumes that significant lytic activity occurs only
against infected T cells at a rate p 2y 1z. Nonlytic activity
inhibits virus entry into cells bearing the CCR5 receptor
at a rate p 1z 1 1. Infection of CXCR4-expressing T cells
is not inhibited by nonlytic CD8 cell-mediated activity.
The dynamical properties of this model are explored
numerically. The evolutionarily stable state of coreceptor
usage (q) for different host and viral parameters was
found as follows: Given that a specific virus strain, char-
acterized by a certain value q, has established a persis-
tent infection and has equilibrated, we checked for inva-
sion with a virus strain that has mutated to a different
value of q. If the mutant could invade, it was further
determined whether this led to replacement of the pre-
vious strain or to a coexistence equilibrium. This proce-
dure was iterated until an equilibrium was found that
could not be invaded by any alternative strains.
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